<DOC>
	<DOCNO>NCT00596661</DOCNO>
	<brief_summary>The primary objective trial demonstrate safety feasibility treat coronary artery lesion previously treat TRIMAXX Coronary stent system compare report result commercially available non-drug elute coronary stent system indicate treatment .</brief_summary>
	<brief_title>The TRIMAXX Coronary Stent Trial</brief_title>
	<detailed_description>The TriMaxx study prospective , multicenter , non-randomized , single-arm trial intend demonstrate safety feasibility TriMaxx Cornary Stent System . The study enroll 100 subject de novo native coronary artery lesion meet eligibility criterion agree participate study . Subjects enrol sequential manner . The safety feasibility TRIMAXX stent evaluate compare MACE rate observe 30 day post-procedure MACE rate commercially available non-drug eluting stent . Secoandry evaluation include analysis clinical angiographic parameter 6 month . All subject undergo assessment 30 day 6 month . Additionally , subject undergo follow-up angiogram 6 month .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Eligible catheter base treatment Single coronary lesion require treatment Lesion accessible stent device Completes inform consent participation Stable condition ( symptoms heart attack within 72 hour prior treatment ) Normal lab value Previous treatment affect artery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>coronary stent</keyword>
</DOC>